{"pmid":32387212,"title":"Important considerations regarding the future management of Coronavirus (COVID-19).","text":["Important considerations regarding the future management of Coronavirus (COVID-19).","Int J Surg","Abdul-Rahman, Abbas","Abdallah, Abbas","Yousif, Ali","Memon, Sara Fatima","32387212"],"journal":"Int J Surg","authors":["Abdul-Rahman, Abbas","Abdallah, Abbas","Yousif, Ali","Memon, Sara Fatima"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387212","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ijsu.2020.04.083","keywords":["covid-19","coronavirus","immunity","public health","sars-cov-2","world health organisation (who)"],"topics":["Prevention"],"weight":1,"_version_":1666428892553936896,"score":9.490897,"similar":[{"pmid":32362362,"pmcid":"PMC7152892","title":"COVID-19: Timing is Important.","text":["COVID-19: Timing is Important.","Eur J Intern Med","de Simone, Giovanni","Mancusi, Costantino","32362362"],"journal":"Eur J Intern Med","authors":["de Simone, Giovanni","Mancusi, Costantino"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32362362","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.ejim.2020.04.019","keywords":["immunity","inflammation","intensive care unit","staging"],"topics":["Treatment"],"weight":1,"_version_":1666138496011599873,"score":54.055763},{"pmid":32391393,"pmcid":"PMC7199282","title":"Digesting the crisis: autophagy and coronaviruses.","text":["Digesting the crisis: autophagy and coronaviruses.","Autophagy is a catabolic pathway with multifaceted roles in cellular homeostasis. This process is also involved in the antiviral response at multiple levels, including the direct elimination of intruding viruses (virophagy), the presentation of viral antigens, the fitness of immune cells, and the inhibition of excessive inflammatory reactions. In line with its central role in immunity, viruses have evolved mechanisms to interfere with or to evade the autophagic process, and in some cases, even to harness autophagy or constituents of the autophagic machinery for their replication. Given the devastating consequences of the current COVID-19 pandemic, the question arises whether manipulating autophagy might be an expedient approach to fight the novel coronavirus SARS-CoV-2. In this piece, we provide a short overview of the evidence linking autophagy to coronaviruses and discuss whether such links may provide actionable targets for therapeutic interventions.","Microb Cell","Carmona-Gutierrez, Didac","Bauer, Maria A","Zimmermann, Andreas","Kainz, Katharina","Hofer, Sebastian J","Kroemer, Guido","Madeo, Frank","32391393"],"abstract":["Autophagy is a catabolic pathway with multifaceted roles in cellular homeostasis. This process is also involved in the antiviral response at multiple levels, including the direct elimination of intruding viruses (virophagy), the presentation of viral antigens, the fitness of immune cells, and the inhibition of excessive inflammatory reactions. In line with its central role in immunity, viruses have evolved mechanisms to interfere with or to evade the autophagic process, and in some cases, even to harness autophagy or constituents of the autophagic machinery for their replication. Given the devastating consequences of the current COVID-19 pandemic, the question arises whether manipulating autophagy might be an expedient approach to fight the novel coronavirus SARS-CoV-2. In this piece, we provide a short overview of the evidence linking autophagy to coronaviruses and discuss whether such links may provide actionable targets for therapeutic interventions."],"journal":"Microb Cell","authors":["Carmona-Gutierrez, Didac","Bauer, Maria A","Zimmermann, Andreas","Kainz, Katharina","Hofer, Sebastian J","Kroemer, Guido","Madeo, Frank"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391393","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.15698/mic2020.05.715","keywords":["covid-19","mers","sars","sars-cov-2","coronavirus","immunity","inflammation","virophagy"],"locations":["Autophagy"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666528580139483138,"score":45.539886},{"pmid":32439309,"title":"[Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications].","text":["[Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications].","The new coronavirus (SARS-CoV-2) that causes a severe acute respiratory syndrome emerges in Wuhan, China, in December 2019. It produces the aforementioned disease due to coronavirus 2019 (COVID-19), and has led to a declaration of a world public health emergency by the World Health Organisation. This new SARS-CoV-2 virus could share characteristics and an immune response similar to those described for other coronavirus. Given its activity on the interferon pathway, and the manner in which it dysregulates innate immunity, the use of treatments directed at modulating or containing this could be of interest. A narrative review was made of the current evidence about immunity against coronavirus and its applicability to SARS-CoV-2. The physiopathogenesis is also described, along with the underlying leucocyte activity, with the intention of clarifying the possible usefulness of inflammatory biomarkers and the development of personalised treatments.","An Pediatr (Barc)","Garcia-Salido, Alberto","32439309"],"abstract":["The new coronavirus (SARS-CoV-2) that causes a severe acute respiratory syndrome emerges in Wuhan, China, in December 2019. It produces the aforementioned disease due to coronavirus 2019 (COVID-19), and has led to a declaration of a world public health emergency by the World Health Organisation. This new SARS-CoV-2 virus could share characteristics and an immune response similar to those described for other coronavirus. Given its activity on the interferon pathway, and the manner in which it dysregulates innate immunity, the use of treatments directed at modulating or containing this could be of interest. A narrative review was made of the current evidence about immunity against coronavirus and its applicability to SARS-CoV-2. The physiopathogenesis is also described, along with the underlying leucocyte activity, with the intention of clarifying the possible usefulness of inflammatory biomarkers and the development of personalised treatments."],"journal":"An Pediatr (Barc)","authors":["Garcia-Salido, Alberto"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32439309","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.anpedi.2020.04.016","keywords":["covid-19","coronavirus","immunity","inmunidad","sars-cov-2"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667535119521415168,"score":44.591625},{"pmid":32267987,"title":"Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.","text":["Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.","The beginning of 2020 has seen the emergence of COVID-19, an outbreak caused by a novel coronavirus, SARS-CoV-2, an important pathogen for humans. There is an urgent need to better understand this new virus and to develop ways to control its spread. In Iran, the first case of the COVID-19 was reported after spread from China and other countries. Fever, cough, and fatigue were the most common symptoms of this virus. In worldwide, the incubation period of COVID-19 was 3 to 7 days and approximately 80% of infections are mild or asymptomatic, 15% are severe, requiring oxygen, and 5% are critical infections, requiring ventilation. To mount an antiviral response, the innate immune system recognizes molecular structures that are produced by the invasion of the virus. COVID-19 infection induces IgG antibodies against N protein that can be detected by serum as early as day 4 after the onset of disease and with most patients seroconverting by day 14. Laboratory evidence of clinical patients showed that a specific T-cell response against SARS-CoV-2 is important for the recognition and killing of infected cells, particularly in the lungs of infected individuals. At present, there is no specific antiviral therapy for COVID-19 and the main treatments are supportive. In this review, we investigated the innate and acquired immune responses in patients who recovered from COVID-19, which could inform the design of prophylactic vaccines and immunotherapy for the future.","Rev Med Virol","Rokni, Mohsen","Ghasemi, Vida","Tavakoli, Zahra","32267987"],"abstract":["The beginning of 2020 has seen the emergence of COVID-19, an outbreak caused by a novel coronavirus, SARS-CoV-2, an important pathogen for humans. There is an urgent need to better understand this new virus and to develop ways to control its spread. In Iran, the first case of the COVID-19 was reported after spread from China and other countries. Fever, cough, and fatigue were the most common symptoms of this virus. In worldwide, the incubation period of COVID-19 was 3 to 7 days and approximately 80% of infections are mild or asymptomatic, 15% are severe, requiring oxygen, and 5% are critical infections, requiring ventilation. To mount an antiviral response, the innate immune system recognizes molecular structures that are produced by the invasion of the virus. COVID-19 infection induces IgG antibodies against N protein that can be detected by serum as early as day 4 after the onset of disease and with most patients seroconverting by day 14. Laboratory evidence of clinical patients showed that a specific T-cell response against SARS-CoV-2 is important for the recognition and killing of infected cells, particularly in the lungs of infected individuals. At present, there is no specific antiviral therapy for COVID-19 and the main treatments are supportive. In this review, we investigated the innate and acquired immune responses in patients who recovered from COVID-19, which could inform the design of prophylactic vaccines and immunotherapy for the future."],"journal":"Rev Med Virol","authors":["Rokni, Mohsen","Ghasemi, Vida","Tavakoli, Zahra"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267987","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/rmv.2107","keywords":["2019-ncov disease","b cell","covid-19","sars-cov-2","t cell","coronavirus","immunity"],"locations":["Iran","China","Iran"],"countries":["China","Iran, Islamic Republic of"],"countries_codes":["CHN|China","IRN|Iran, Islamic Republic of"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138491888599040,"score":42.36788},{"pmid":32388476,"title":"Is copper beneficial for COVID-19 patients?","text":["Is copper beneficial for COVID-19 patients?","Copper (Cu) is an essential micronutrient for both pathogens and the hosts during viral infection. Cu is involved in the functions of critical immune cells such as T helper cells, B cells, neutrophils natural killer (NK) cells, and macrophages. These blood cells are involved in the killing of infectious microbes, in cell-mediated immunity and the production of specific antibodies against the pathogens. Cu-deficient humans show an exceptional susceptibility to infections due to the decreased number and function of these blood cells. Besides, Cu can kill several infectious viruses such as bronchitis virus, poliovirus, human immunodeficiency virus type 1(HIV-1), other enveloped or nonenveloped, single- or double-stranded DNA and RNA viruses. Moreover, Cu has the potent capacity of contact killing of several viruses, including SARS-CoV-2. Since the current outbreak of the COVID-19 continues to develop, and there is no vaccine or drugs are currently available, the critical option is now to make the immune system competent to fight against the SARS-CoV-2. Based on available data, we hypothesize that enrichment of plasma copper levels will boost both the innate and adaptive immunity in people. Moreover, owing to its potent antiviral activities, Cu may also act as a preventive and therapeutic regime against COVID-19.","Med Hypotheses","Raha, Syamal","Mallick, Rahul","Basak, Sanjay","Duttaroy, Asim K","32388476"],"abstract":["Copper (Cu) is an essential micronutrient for both pathogens and the hosts during viral infection. Cu is involved in the functions of critical immune cells such as T helper cells, B cells, neutrophils natural killer (NK) cells, and macrophages. These blood cells are involved in the killing of infectious microbes, in cell-mediated immunity and the production of specific antibodies against the pathogens. Cu-deficient humans show an exceptional susceptibility to infections due to the decreased number and function of these blood cells. Besides, Cu can kill several infectious viruses such as bronchitis virus, poliovirus, human immunodeficiency virus type 1(HIV-1), other enveloped or nonenveloped, single- or double-stranded DNA and RNA viruses. Moreover, Cu has the potent capacity of contact killing of several viruses, including SARS-CoV-2. Since the current outbreak of the COVID-19 continues to develop, and there is no vaccine or drugs are currently available, the critical option is now to make the immune system competent to fight against the SARS-CoV-2. Based on available data, we hypothesize that enrichment of plasma copper levels will boost both the innate and adaptive immunity in people. Moreover, owing to its potent antiviral activities, Cu may also act as a preventive and therapeutic regime against COVID-19."],"journal":"Med Hypotheses","authors":["Raha, Syamal","Mallick, Rahul","Basak, Sanjay","Duttaroy, Asim K"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32388476","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.mehy.2020.109814","keywords":["blood cells","covid-19","contact killing","copper","coronavirus","cu-deficiency","cuonps","cupric chloride","immunity","ros","sars-cov-2","th1/th2 cells","viral infection"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666428892667183104,"score":42.36788}]}